Dr. Marta Dahiya, a board-certified radiation oncologist, focuses the bulk of her work on breast and gynecological cancers. Committed to ensuring that all patients have access to the treatments that they need, Dr. Marta Dahiya maintains an in-depth knowledge of radiotherapy treatments for cancer. In late March of 2016, a research team at Main Line Health's Lakenau Institute for Medical Research in Pennsylvania announced the development of a new targeted approach for ovarian cancer.
Most women with the disease undergo ovary removal followed by chemotherapy, which often eliminates the initial cancer but leaves the patient vulnerable to the grow. Dr. Marta Dahiya has dedicated herself to increasing accessibility of breast cancer treatments. Dr. Marta Dahiya works to bring new treatments to developing nations, where the survival rates are lowest. Of the more than 500,000 women estimated to have lost their lives to breast cancer in 2011, approximately 58 percent likely lived in less developed countries. Although the number of diagnosed cases in these countries can be half that of nations in Western Europe, the prevalence of the disease is rising. Survival rates, however, remain below 40 percent, as compared to 80 percent or more in many high-income countries.
The World Health Organization attributes the disparity in survival rates to the lack of early detection and proper diagnosis, which increases the prevalence of patients in the later stages of breast cancer. The organization also notes an insufficiency of treatment facilities equipped to deal with disease at multiple stages.